Biodesix, Inc. (BDSX) Q2 2025 Earnings Call Transcript
2025-08-09 11:07:47 ET
Biodesix, Inc. (BDSX)
Q2 2025 Earnings Conference Call
August 07 2025, 04:30 PM ET
Company Participants
Robin Harper Cowie - CFO, Secretary & Treasurer
Scott Hutton - President, CEO & Director
Conference Call Participants
Alexander Davis Vukasin - Canaccord Genuity Corp., Research Division
Andrew Frederick Brackmann - William Blair & Company L.L.C., Research Division
Thomas Flaten - Lake Street Capital Markets, LLC, Research Division
William Ruby - TD Cowen, Research Division
William Bishop Bonello - Craig-Hallum Capital Group LLC, Research Division
Christopher F. Brinzey - Westwicke Partners, LLC
Presentation
Operator
Good day, and thank you for standing by. Welcome to the Biodesix Q2 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded....
Read the full article on Seeking Alpha
For further details see:
Biodesix, Inc. (BDSX) Q2 2025 Earnings Call TranscriptNASDAQ: BDSX
BDSX Trading
1.26% G/L:
$19.28 Last:
37,157 Volume:
$19.30 Open:



